Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Boehringer Ingelheim drug GLYXAMBI appeared…
New patent for Boehringer Ingelheim drug GLYXAMBI Read Post »
Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. The generic ingredient in MYFEMBREE is estradiol; norethindrone acetate; relugolix.…
The post New patent for Myovant Sciences drug…
Annual Drug Patent Expirations for EVEKEO+ODT Evekeo Odt is a drug marketed by Arbor Pharms Llc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Arbor Pharms drug EVEKEO ODT appeared first on DrugPatentW…
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are thirteen patents protecting this drug. XHANCE drug…
The post New patent for Optinose Us drug XHANCE appeared first on DrugPaten…
Annual Drug Patent Expirations for MYRBETRIQ+GRANULES Myrbetriq Granules is a drug marketed by Apgdi and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for APGDI drug MYRBETRIQ GRANULES appeared f…
Annual Drug Patent Expirations for SUTAB+%28COPACKAGED%29 Sutab (copackaged) is a drug marketed by Braintree Labs and is included in one NDA. It is available from one supplier. There is one…
The post New patent for Braintree Labs drug SUTAB (COPACKAGED…
New patent for Braintree Labs drug SUTAB (COPACKAGED) Read Post »
Annual Drug Patent Expirations for LEVULAN Levulan is a drug marketed by Dusa and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for DUSA drug LEVULAN appeared first on DrugPatentWatch – M…
Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first o…
Annual Drug Patent Expirations for NOXAFIL Noxafil is a drug marketed by Merck Sharp Dohme and Schering and is included in three NDAs. It is available from three suppliers. There…
The post New patent for Merck Sharp drug NOXAFIL appeared first on DrugP…
Annual Drug Patent Expirations for PERSERIS+KIT Perseris Kit is a drug marketed by Indivior Inc and is included in one NDA. It is available from one supplier. There are seven…
The post New patent for Indivior Inc drug PERSERIS KIT appeared first on Dru…